There was no difference in disease control rate and incidence of toxic side effects between the two groups (P>0.05) . Conclusion: FLOT and FOLFOX are both effective chemotherapy regimens for mid to late stage GC, with consistent safety. However, the former has advantages in improving objective ...
There was no difference in disease control rate and incidence of toxic side effects between the two groups (P>0.05) . Conclusion: FLOT and FOLFOX are both effective chemotherapy regimens for mid to late stage GC, with consistent safety. However, the former ...
confirming the absence of disease with a sensitive imaging modality in patients with rising PSA may help support the decision to delay initiation of systemic therapy (androgen deprivation therapy/novel hormone therapy, chemotherapy, or both), which is also associated with significant side effects.3...
There is no preference for postoperative chemotherapy with the two common treatment regimens, FLOT and FOLFOX, in these patients. The aim of this study was to compare FOLFOX and FLOT regimens in perioperative chemotherapy in resectable GC based on pathological response and complications. Methods: ...